Table 1 Demographics and clinical profile of patients at baseline.
N | % | ||
|---|---|---|---|
Sex | Female | 65 | 71.4 |
Male | 26 | 28.6 | |
5-HTTLPR genotype | LALA | 26 | 28.6 |
Non-LALA | 65 | 71.4 | |
Syndromal anxious depression | Yes | 42 | 46.2 |
No | 49 | 53.8 | |
Anxious depression | Yes | 75 | 82.4 |
No | 16 | 17.6 | |
Severity of MDD | Severe | 32 | 35 |
Moderate | 59 | 65 | |
Mean (SD) | n | Range | |
Age (years) | 27.1 (8.2) | 91 | 18.3–57.3 |
Factor score | 7.9 (2.0) | 91 | 3–15 |
GAD-10 score | 24.0 (9.3) | 89 | 7–47 |
HAMD17 score | 22.9 (3.4) | 91 | 18–31 |
HAMD6 score | 12.3 (1.6) | 91 | 7–17 |
Years of education | 11.6 (1.1) | 76 | 5–12 |
Body mass index (kg/m2) | 24.5 (5.6) | 91 | 17–45 |
Injected dose (MBq) | 577.4 (56) | 91 | 263–615 |
Injected mass/kg (µg/kg) | 0.013 (0.015) | 91 | 0.004–0.082 |
Cerebellum, area under curve (kBq/ml) | 10.3 (2.6) | 91 | 3.9–17.8 |
